[Research progress of effect of berberine in treatment of ulcerative colitis based on cell signaling pathway]

Zhongguo Zhong Yao Za Zhi. 2021 Jan;46(1):33-40. doi: 10.19540/j.cnki.cjcmm.20201002.601.
[Article in Chinese]

Abstract

Berberine is the main extract of Coptis chinensis, and its anti-inflammatory, antioxidant, antibacterial and immunomodulatory effects have been confirmed by modern studies. Ulcerative colitis(UC) is a chronic, idiopathic inflammatory bowel disease with unknown etiology. Its causes involve genetics, intestinal microecology and mucosal immune system disorders. In this paper, literatures on relevant pathways and mechanism of berberine on ulcerative colitis in recent years were consulted and summarized to provide me-thods and ideas for developing berberine in the treatment of UC and exploring the mechanisms. The results showed that berberine protects the intestinal mucosal barrier, restores the body's normal immune response, and improves oxidative stress by regulating multiple signaling pathways, such as JAK-STAT, NK-κB, PI3 K-AKT, MAPK, Nrf2, ERS, and MLCK-MLC, so as to treat UC.

Keywords: berberine; cell signaling pathway; intestinal barrier mechanism; ulcerative colitis.

MeSH terms

  • Berberine* / pharmacology
  • Colitis*
  • Colitis, Ulcerative* / drug therapy
  • Colitis, Ulcerative* / genetics
  • Humans
  • Intestinal Mucosa
  • Signal Transduction

Substances

  • Berberine